Search clinical trials for: POLA-R-CHP

Total 5641 results

Sun Yat-sen University

Not yet recruiting

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

Diffuse Large B Cell Lymphoma (DLBCL)

China
Ruijin Hospital

Not yet recruiting

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

DLBCL - Diffuse Large B Cell Lymphoma | Double Expressor Lymphoma

China
Fudan University

Recruiting

Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET

Diffuse Large B-Cell Lymphoma | DLBCL

China
Ruijin Hospital

Not yet recruiting

Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP

DLBCL - Diffuse Large B Cell Lymphoma | DHL | THL
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes (Pola-ZRCHP)

Diffuse Large B-Cell Lymphoma (DLBCL)

China
Beijing Tongren Hospital

Recruiting

Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma

Diffuse Large B Cell Lymphoma (DLBCL)

China
The First Affiliated Hospital of Soochow University

Recruiting

Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation

Diffuse Large B-Cell Lymphoma (DLBCL)

China
Nordic Lymphoma Group
Roche Pharma AG

Recruiting

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma (POLAR BEAR)

Diffuse Large B Cell Lymphoma | DLBCL

Finland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
Fudan University

Recruiting

POLA-R-CHP in the First-line Treatment of Transformed DLBCL

Transformed Lymphoma

China
Second Affiliated Hospital, School of Medicine,...
Zhejiang Cancer Hospital; Second Affiliated Hospital of Wenzhou Medical University and other collaborators

Recruiting

Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma (DLBCL)

China
AstraZeneca

Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Untreated Follicular Lymphoma

United States, Spain, Australia, China, Belgium, India, Thailand, United Kingdom, Hong Kong, Canada, Hungary, Japan, Czechia, Taiwan, Brazil, Denmark, Poland, Sweden, Puerto Rico, Finland, South Korea
Fondazione Italiana Linfomi ONLUS

Unknown

Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma

Follicular Lymphoma

Italy
Sun Yat-sen University

Not yet recruiting

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Diffuse Large B-Cell Lymphoma (DLBCL) | CD5 Positive

China
The University of Texas Health Science Center at...

Withdrawn

Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy

Lymphoma, B-Cell

United States
AstraZeneca

Recruiting

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL (SOUNDTRACK-D2)

Large B-cell Lymphoma

China, Belgium, Australia, Canada, Japan, United Kingdom, Brazil, Poland, Hong Kong, South Korea, Turkey (Türkiye)
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation

Aortic Valve Stenosis | Aortic Valve Disease

United States
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS

EBV-Positive Diffuse Large B-Cell Lymphoma, Nos | Brentuximab Vedotin

China
Second Affiliated Hospital of Nanchang University

Enrolling by invitation

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Lymphoma, Large-Cell, Diffuse

China
Dana-Farber Cancer Institute
Genentech, Inc.

Active, not recruiting

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Richter Syndrome

United States
CTI BioPharma

Completed

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin (RAPID)

Diffuse Large-Cell Lymphoma

United States, Germany, Canada, Italy, France
Ruijin Hospital

Unknown

R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B

Diffuse Large B-cell Lymphoma | Follicular Lymphoma Grade 3B

China
Ruijin Hospital

Not yet recruiting

Dynamic CtDNA-guided Targeted Therapy in DLBCL

Diffuse Large B Cell Lymphoma (DLBCL)
Nanjing Yoko Biomedical Co., Ltd.

Recruiting

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Diffuse Large B-Cell Lymphoma, Unspecified Site

China
Li Zhiming

Not yet recruiting

Zanubrutinib, Chidamide, and Rituximab Induction with or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Double Express Diffuse Large B-cell Lymphoma | Histone Deacetylase Inhibitor | BTK Inhibitors

China
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Withdrawn

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma (FIL_POLARDHAP)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma Refractory

Italy
Erica Goldstein

Completed

Effect of Carbohydrate-protein Co-ingestion on Short-term Recovery

Dietary Supplementations

United States
PATH
GlaxoSmithKline; Icahn School of Medicine at Mount Sinai; Duke University; Children... and other collaborators

Completed

Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine

Influenza | Vaccine

United States
Sun Yat-sen University

Recruiting

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Diffuse Large B-Cell Lymphoma

China
Shandong Cancer Hospital and Institute
The First Affiliated Hospital of Nanchang University

Recruiting

A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma

The First Affiliated Hospital of Nanchang University

China
Dizal Pharmaceuticals

Recruiting

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

Diffuse Large B-Cell Lymphoma

China
Sun Yat-sen University

Recruiting

Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

China
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older

Acute Myeloid Leukemia
Mingzhi Zhang

Unknown

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Shandong Provincial Hospital

Recruiting

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin Lymphoma

China
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]

Gluteal Skin Irregularities

Canada
Pitié-Salpêtrière Hospital

Completed

Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery (QASH)

Hemorrhage | Cardiac Surgery | Hemorrhagic Shock

France
University of Wisconsin, Madison

Completed

R-CHOP + GM-CSF for Previously Untreated LCL in Elderly

Lymphoma, Large B-Cell, Diffuse

United States
The University of Tennessee, Knoxville

Completed

Carbohydrate-Protein Supplementation During Endurance Running

Supplementation During Endurance Performance

United States
Fondazione Italiana Linfomi - ETS

Completed

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Lymphoma | Large B-Cell | Diffuse Large B-Cell

Italy
Sun Yat-sen University
Fudan University

Recruiting

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

Diffuse Large B Cell Lymphoma

China
Sinclair Pharmaceuticals Limited

Not yet recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit

Jawline Contour Deficit

China
Shandong Provincial Hospital

Unknown

Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

Lymphoma, Non-Hodgkin;Hodgkin Disease

China
AHS Cancer Control Alberta
Hoffmann-La Roche

Completed

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma (PET-Chop)

Diffuse Large B Cell Lymphoma

Canada
Lymphoma Study Association

Completed

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

Diffuse Large B-Cell Lymphoma
Sun Yat-sen University

Recruiting

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

DLBCL

China
The Catholic University of Korea

Active, not recruiting

Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Lymphoma, Large B-Cell, Diffuse

Korea, Republic of
Université de Sherbrooke

Completed

Effect of a Two-month Carbohydrate-restricted Diet on Energy Metabolism in a Seniors' Residence (SAGE)

Healthy Aging

Canada
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

DLBCL - Diffuse Large B Cell Lymphoma | Double-expressor Lymphoma (DEL) | Chidamide | R-CHOP Chemotherapy

China
Sun Yat-sen University

Active, not recruiting

Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCL (SCREEN)

Newly Diagnosed MYC/BCL2 Double-expressor DLBCL

China
Spectrum Pharmaceuticals, Inc
CTI BioPharma

Terminated

Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)

Lymphoma, Follicular | Follicular Lymphoma

United States

Search clinical trials for: POLA-R-CHP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations